← Open Payments lookup

MARC EXILUS: Open Payments

NPI 1588149587 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$392 in 10 payments from 5 companies in 2025. Trend: 2023 $193 · 2024 $76 · 2025 $392

Food & beverage: $392
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc1$117
Neurocrine BioSciences, Inc.4$90
Otsuka America Pharmaceutical, Inc.2$84
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$62
Lundbeck LLC2$39

Products named: SPRAVATO, INGREZZA, REXULTI, CAPLYTA, ABILIFY ASIMTUFII.

Industry payments across DE — which companies pay providers there.